Business Context and Reporting Period
This Form 8-K is filed by Sonim Technologies, Inc. (not DNA X, Inc.) on February 21, 2023, reporting events occurring on February 14, 2023. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol "SONM". The filing addresses a critical regulatory status regarding its continued listing on the exchange.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock price thresholds rather than operational financial performance.
Material Changes and Events
- Delisting Notice: On February 14, 2023, the Company received notice from the Nasdaq Listing Qualifications Department that it failed to satisfy the minimum $1.00 per share closing bid price requirement (Nasdaq Listing Rule 5550(a)(2)).
- Compliance Period Expiration: The Company had previously been granted two consecutive 180-calendar day periods to regain compliance, which expired on February 13, 2023.
- Current Status: The Company is subject to delisting unless it successfully requests and obtains a hearing before a Nasdaq Hearings Panel.
Guidance, Outlook, and Risks
- Management Action: On February 21, 2023, the Company requested a hearing before the Nasdaq Hearings Panel to present its plan to regain compliance and request an extension of time.
- Uncertainty: Management explicitly states there can be no assurance that the Panel will grant the request for continued listing, that the Company will regain compliance, or that it can do so within any granted timeframe.
- Disclosure: A press release detailing the Company's strategy was issued on February 21, 2023, and is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the current trading price of SONM to assess the gap from the $1.00 minimum bid price requirement.
- Monitor the outcome of the hearing before the Nasdaq Hearings Panel scheduled after February 21, 2023.
- Review the press release (Exhibit 99.1) for specific details on the Company's plan to regain compliance.
- Check for subsequent filings regarding the final decision on the delisting determination.